Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,334
datasets available to search
ShareScore release 0.9.0
Dataset results
1,334 results for “Hematology”
NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders
ClinicalTrials.gov study NCT00053989. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders
ClinicalTrials.gov study NCT00856388. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Pembrolizumab/Vibostolimab (MK-7684A) in Relapsed/Refractory Hematological Malignancies (MK-7684A-004, KEYVIBE-004)
ClinicalTrials.gov study NCT05005442. IPD Sharing: YES. Countries: 16. Publications: 0.
Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic
ClinicalTrials.gov study NCT02500550. IPD Sharing: NO. Countries: 6. Publications: 0.
Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies
ClinicalTrials.gov study NCT00150462. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparison of Multigam IV (5% vs. 10%) in Patients With an Immunodeficiency Secondary to a Hematological Disorder
ClinicalTrials.gov study NCT03250845. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations
ClinicalTrials.gov study NCT02418000. IPD Sharing: NO. Countries: 1. Publications: 0.
Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Can
ClinicalTrials.gov study NCT00118352. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases
ClinicalTrials.gov study NCT00453206. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies
ClinicalTrials.gov study NCT03465540. IPD Sharing: YES. Countries: 6. Publications: 0.
T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases
ClinicalTrials.gov study NCT00589602. IPD Sharing: NO. Countries: 1. Publications: 0.
Feasibility and Cost Analysis of PBSC Mobilization Using Pegfilgrastim in Hematologic Malignancies
ClinicalTrials.gov study NCT00689884. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
ClinicalTrials.gov study NCT05646576. IPD Sharing: YES. Countries: 1. Publications: 0.
Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers
ClinicalTrials.gov study NCT04083170. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 0/1 Biomarker and Pharmacodynamic Study of Roflumilast in Patients With Advanced B-Cell Hematologic Malignancies (CTRC# 13-0013)
ClinicalTrials.gov study NCT01888952. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies
ClinicalTrials.gov study NCT00145626. IPD Sharing: Not stated. Countries: 1. Publications: 0.
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
ClinicalTrials.gov study NCT05093335. IPD Sharing: YES. Countries: 1. Publications: 0.
CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
ClinicalTrials.gov study NCT06326463. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of HMPL-306 in Advanced Hematological Malignancies With mIDH
ClinicalTrials.gov study NCT04764474. IPD Sharing: NO. Countries: 2. Publications: 0.
Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases
ClinicalTrials.gov study NCT00038857. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.